Overview

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Status:
Unknown status
Trial end date:
2005-09-01
Target enrollment:
0
Participant gender:
All
Summary
Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Glucagon
Glucagon-Like Peptide 1
Morphine
Criteria
Inclusion Criteria:

- normal volunteer

- living liver donor

Exclusion Criteria:

- COPD

- chronic liver disease

- hypersensitive to glucagon

- DM

- insulinoma

- glucagonoma

- pregnancy